Found 13 matching trials
Intermediate Expanded Access Protocol CNMAu8.EAP03 N/A This is a single-center intermediate expanded access program to provide acc...
Show More Status
Temporarily Not Available
Location
University of Texas Southwestern
Learn More & Join Trial
Three Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01, CNMAu8.EAP02, and CNMAu8.EAP06 for ALS N/A The primary objective of the intermediate expanded access protocol is to pr...
Show More Location
Barrow Neurological Institute (Enrollment is full, not recruiting)
Learn More & Join Trial
HEALEY ALS Platform Trial - Regimen C CNM-Au8 PHASE2 The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen cl...
Show More Location
Healey Center for ALS at Mass General
Learn More & Join Trial
An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS PHASE2 This is an optional open-label extension to participants that have complete...
Show More Status
Active Not Recruiting
Learn More & Join Trial
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease PHASE2 REPAIR-PD is a single-center open label pilot, sequential group, investigat...
Show More Learn More & Join Trial
Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) PHASE2 The objective of this trial was to assess the efficacy, safety, and PK/PD e...
Show More Location
University of Sydney Brain and Mind Centre
Learn More & Join Trial
Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis PHASE2 The objective of this trial is to assess the efficacy and safety of CNM-Au8...
Show More Location
UT Southwestern Medical Center
Learn More & Join Trial
A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers PHASE1 This is a Phase 1, First-Time-In-Humans, randomized, placebo-controlled, do...
Show More Location
Centre for Human Drug Research (CHDR)
Learn More & Join Trial
A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis PHASE2 Open-label, long-term extension study available to participants who have co...
Show More Location
Sydney Brain Mind Centre
Learn More & Join Trial
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis. PHASE2 REPAIR-MS is a single-center open label, sequential group, investigator and...
Show More Location
University of Texas Southwestern
Learn More & Join Trial